Bristol-myers Squibb

Reports indicate that pharmaceutical giants AstraZeneca and Bristol-Myers Squibb (BMS) are in talks regarding a potential merger. If successful, the deal could create a combined entity with a market capitalization of nearly $400 billion, marking one of the largest transactions in industry history.